Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
4.120
+0.040 (0.98%)
Nov 20, 2024, 4:00 PM EST - Market closed
Kyverna Therapeutics Employees
Kyverna Therapeutics had 96 employees as of December 31, 2023.
Employees
96
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,152,656
Market Cap
177.87M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 96 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Caribou Biosciences | 158 |
| Nkarta | 150 |
| Tenaya Therapeutics | 140 |
| BrainsWay | 134 |
| Stereotaxis | 122 |
| Verastem | 73 |
| DiaMedica Therapeutics | 19 |
| Galectin Therapeutics | 14 |
KYTX News
- 6 days ago - Kyverna Therapeutics Announces New Patient Data Highlighting Potential of KYV-101 for Treatment of Lupus Nephritis in Symposium at ACR Convergence 2024 - PRNewsWire
- 7 days ago - Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results - PRNewsWire
- 4 weeks ago - Kyverna Therapeutics Appoints Mert Aktar to its Board of Directors - PRNewsWire
- 2 months ago - Kyverna Therapeutics Presents Patient Data Reinforcing Potential of KYV-101 for Treatment of Neuroinflammatory Diseases in Symposium at ECTRIMS 2024 - PRNewsWire
- 2 months ago - Kyverna Therapeutics Announces Leadership Update - PRNewsWire
- 2 months ago - Kyverna Therapeutics, Inc. May Have Committed Securities Fraud And The Schall Law Firm Encourages Shareholders To Join An Inquiry - Accesswire
- 2 months ago - The Schall Law Firm Is Looking Into Whether Kyverna Therapeutics Inc Violated Securities Laws And Investors Are Invited To Participate - Accesswire
- 2 months ago - Shareholders With Losses In Kyverna Therapeutics, Inc. Should Contact The Schall Law Firm About A Securities Fraud Investigation - Accesswire